|
Uro-Fit Kidney and Bladder Formula Herbal Formula Combining Cranberry, Chanca Piedra,
Dandelion Root and Uva Ursi Daily "Uro-Fit" Kidney and Bladder Formula
includes the best in nutritional ingredients known to traditional and
modern health science for maintaining a healthy urinary tract. However,
please do not simply take our word for that - study it for yourself. We
have included a sampling of the research available. We have made a
sincere effort to include a representative sampling of the available
studies, including those showing both strong and weak results. Many more
studies can be found by searching the National Library of Medicine at
www.pubmed.gov. It is important to realize that when searching the
database at the National Library of Medicine you will find many studies
supporting the use of Cranberry, Chanca Piedra, Dandelion Root, and Uva
Ursi for conditions other than the urinary tract. This testifies to the
fact that Uro-Fit would benefit anyone, even if they do not need urinary
tract support. However, this combination has the strongest research
backing for improving urinary health. Cranberry Research The cranberry powder used in Uro-Fit has been
awarded an approved health claim for urinary health by the Korean Food
and Drug Administration
(KFDA) and their review of the clinical data. A list of research studies can also be found at:
http://www.decasbotanical.com/documents/Studies%20Listed%2002%2024%2010.pdf 1. Vidlar A, Vostalova J, Ulrichova J, Student V,
Stejskal D, Reichenbach R, Vrbkova J, Ruzicka F, and Simanek V. (2010)
The effectiveness of dried cranberries (Vaccinium macrocarpon) in men
with lower urinary tract symptoms. British Journal of Nutrition
104:1181-1189. Link to full text: 2. Sengupta K, Alluri KV, Golaakoti T, Gottumukkala
GV, Raavi L, Kotchrlakota L, Soigalan SC, Dey D, and Chatterjeee A. A
randomized, double blind, controlled, dose-dependent clinical trial to
evaluate the efficacy of a proanthocyanidin standarized whole cranberry
(vaccinium macrocarpon) powder on infections of the urinary tract.
(2011) Current Bioactive Compounds 7:39-46. Link to full text:
http://www.decasbotanical.com/documents/UTICranberryFinal2010.pdf
Phytomedicine. 2012 Feb 3. [Epub ahead of print]
3.
Wojnicz D,
Sycz Z,
Walkowski S,
Gabrielska J,
Aleksandra W,
Alicja K,
Anna SL,
Hendrich AB.
Study on the influence of cranberry extract Żuravit S·O·S(®) on the
properties of uropathogenic Escherichia coli strains, their ability to
form biofilm and its antioxidant properties.
Phytomedicine. 2012 Feb 3. [Epub ahead of print].
Link
to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/22306419 4.
Stapleton AE,
Dziura J,
Hooton TM,
Cox ME,
Yarova-Yarovaya Y,
Chen S,
Gupta K.
Recurrent urinary tract infection and urinary Escherichia coli in women
ingesting cranberry juice daily: a randomized controlled trial.
Mayo Clin Proc.
2012 Feb;87(2):143-50.
Link
to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/22305026
5.
Laplante KL,
Sarkisian SA,
Woodmansee S,
Rowley DC,
Seeram NP.
Phytother Res.
2012 Effects of Cranberry Extracts on Growth and
Biofilm Production of Escherichia coli and Staphylococcus species.
Feb 1. doi: 10.1002/ptr.4592. [Epub ahead of print]
Link
to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/22294419
6.
Salo J,
Uhari M,
Helminen M,
Korppi M,
Nieminen T,
Pokka T,
Kontiokari T.Cranberry juice for the prevention of recurrences of urinary tract
infections in children: a randomized placebo-controlled trial.
Clin Infect Dis. 2012 Feb 1;54(3):340-6. Epub 2011 Nov 18.
Link
to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/22100577 7.
Suzanne E Geerlings Should we prevent or even treat
urinary tract infections with cranberries?
Future MicrobiologyDecember
2011, Vol. 6, No. 12, Pages 1385-1386 .
Link
to Full Text:
http://www.futuremedicine.com/doi/pdf/10.2217/fmb.11.115
8.
Shmuely H,
Ofek I,
Weiss EI,
Rones Z,
Houri-Haddad Y.Cranberry components for the therapy of infectious disease.
Curr Opin Biotechnol.
2011 Nov 14. [Epub ahead of print]
Link
to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/22088310
9.
Ermel G,
Georgeault S,
Inisan C,
Besnard M.
Inhibition of adhesion of uropathogenic Escherichia coli bacteria to
uroepithelial cells by extracts from cranberry.
J Med Food.
2012 Feb;15(2):126-34. Epub 2011 Nov 14. Link to abstract:
http://www.ncbi.nlm.nih.gov/pubmed/22082066
10.
Iswaldi I,
Gómez-Caravaca AM,
Arráez-Román D,
Uberos J,
Lardón M,
Segura-Carretero A,
Fernández-Gutiérrez A.
Characterization by high-performance liquid
chromatography with diode-array detection coupled to time-of-flight mass
spectrometry of the phenolic fraction in a cranberry syrup used to
prevent urinary tract diseases, together with a study of its
antibacterial activity.
J Pharm Biomed Anal.
2012 Jan 25;58:34-41. Epub 2011 Oct 1.
Link
to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/22018892
11.
Hidalgo G,
Chan M,
Tufenkji N.
Inhibition of Escherichia coli CFT073 fliC expression and
motility by
cranberry materials.
Appl Environ Microbiol. 2011 Oct;77(19):6852-7. Epub 2011 Aug
5. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/21821749 12.
Beerepoot MA,
ter Riet G,
Nys S,
van der Wal WM,
de Borgie CA,
de Reijke TM,
Prins JM,
Koeijers J,
Verbon A,
Stobberingh E,
Geerlings SE. Cranberries vs antibiotics to prevent
urinary tract infections: a randomized double-blind
noninferiority trial in premenopausal women.
Arch Intern Med. 2011 Jul 25;171(14):1270-8. 13.
Cowan CC,
Hutchison C,
Cole T,
Barry SJ,
Paul J,
Reed NS,
Russell JM.
A randomised double-blind placebo-controlled trial to determine the effect
of cranberry juice on decreasing the incidence of urinary symptoms and
urinary tract infections in patients undergoing radiotherapy for cancer
of the bladder or cervix.
Clin Oncol (R Coll Radiol).
2012 Mar;24(2):e31-8. Epub 2011 Jun 23. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/21703829 14.
Tao Y,
Pinzón-Arango PA,
Howell AB,
Camesano TA. Oral consumption of
cranberry juice cocktail inhibits molecular-scale
adhesion of clinical uropathogenic Escherichia coli.
J Med Food. 2011 Jul-Aug;14(7-8):739-45. Epub 2011 Apr 11. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/21480803
15.
Huang Y,
Nikolic D,
Pendland S,
Doyle BJ,
Locklear TD,
Mahady GB. Effects of
cranberry
extracts and ursolic acid derivatives on P-fimbriated Escherichia coli,
COX-2 activity, pro-inflammatory cytokine release and the NF-kappabeta
transcriptional response in vitro.
Pharm Biol. 2009;47(1):18-25.
Link to Full Text:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2849675/pdf/nihms-190676.pdf 16.
Wing DA,
Rumney PJ,
Preslicka CW,
Chung JH. Daily
cranberry
juice for the prevention of asymptomatic bacteriuria
in pregnancy: a randomized, controlled pilot study.
J
Urol. 2008 Oct;180(4):1367-72. Epub 2008 Aug 15.
Link to Free Full Text:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631561/pdf/nihms70398.pdf 17.
Barbosa-Cesnik C,
Brown MB,
Buxton M,
Zhang L,
DeBusscher J,
Foxman B. Cranberry
juice fails to prevent recurrent
urinary tract infection: results from a randomized
placebo-controlled trial.
Clin Infect Dis. 2011 Jan 1;52(1):23-30.
Link to Free Full Text:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060891/pdf/ciq073.pdf
18.
Vidlar A,
Vostalova J,
Ulrichova J,
Student V,
Stejskal D,
Reichenbach R,
Vrbkova J,
Ruzicka F,
Simanek V.
The effectiveness of dried cranberries ( Vaccinium macrocarpon) in men
with lower urinary tract symptoms.
Br J Nutr.
2010 Oct;104(8):1181-9. Epub 2010 Aug 31.
Link
to Free Full Text:
http://journals.cambridge.org/download.php?file=%2FBJN%2FBJN104_08%2FS0007114510002059a.pdf&code=b7ca2441dde5e518a239898b8d35813a
19.
Côté J,
Caillet S,
Doyon G,
Sylvain JF,
Lacroix M. Bioactive compounds in cranberries and
their biological properties.
Crit Rev Food Sci Nutr. 2010 Aug;50(7):666-79. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/20694928 20.
Jepson RG,
Craig JC. Cranberries for preventing
urinary tract infections.
Cochrane Database Syst Rev. 2008 Jan
23;(1):CD001321. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/18253990 21.
Jerry Avorn,
Mark Monane,
Jerry H. Gurwitz,
Robert J. Glynn,
Igor
Choodnovskiy,
Lewis A.
Lipsitz. Reduction
of Bacteriuria and Pyuria After Ingestion of
Cranberry
Juice .
JAMA.
1994;271(10):751-754.
Link to Abstract:
http://jama.ama-assn.org/content/271/10/751.abstract?sid=cc85bce5-985f-42e3-8866-9139c2315eb2 22.
Amy B. Howell, Ph and
Betsy Foxman, PhD.
Cranberry Juice and Adhesion of Antibiotic-Resistant Uropathogens.
JAMA 2002; 271(10):751-754.
Link to Full Text:
http://jama.ama-assn.org/content/287/23/3082.long
23. Stothers L. A randomized
trial to evaluate effectiveness and ost effectiveness of naturopathic
cranberry products as prophylaxis against urinary tract infection in
women. The Canadian Journal or Urology 2002; 9:1558-1562.
Link to Abastract:
http://www.ncbi.nlm.nih.gov/pubmed?term=cranberry%20stothers
24.
Haber SL,
Cauthon KA,
Raney EC.
Cranberry
and warfarin interaction: a case report and review of the literature.Consult Pharm. 2012
Jan;27(1):58-65. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/22231999
25.
Liu H,
Liu H, Wang W, Khoo C, Taylor J, Gu L.Cranberry phytochemicals inhibit glycation of human hemoglobin
and serum albumin by scavenging reactive carbonyls.
Food
Funct. 2011 Aug;2(8):475-82. Epub 2011 Aug 8.
Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/21826359
26. Basu A, Betts NM, Ortiz J, Simmons B, Wu M, Lyons TJ.
Low-energy cranberry
juice decreases lipid oxidation and increases plasma antioxidant
capacity in women with metabolic syndrome.
Nutr Res.
2011 Mar;31(3):190-6. Link to Full Text:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3075541/pdf/nihms276181.pdf 27. Wilson T, Singh AP, Vorsa N, Goettl CD,
Kittleson KM, Roe CM, Kastello GM, Ragsdale FR.
Human glycemic response and phenolic content of unsweetened
cranberry juice.
J Med Food.
2008 Mar;11(1):46-54. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/18361737
28. Wilson T, Meyers SL, Singh AP, Limburg PJ, Vorsa N.
Favorable glycemic response of type 2 diabetics to
low-calorie cranberry
juice.
J Food Sci.
2008 Nov;73(9):H241-5. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/19021808 29. Ruel G, Pomerleau S, Couture P, Lemieux S,
Lamarche B, Couillard C.
Plasma matrix metalloproteinase (MMP)-9 levels are reduced
following low-calorie
cranberry juice
supplementation in men.
J Am Coll Nutr.
2009 Dec;28(6):694-701. Link to Full Text:
http://www.jacn.org/content/28/6/694.full.pdf+html
Chanca Piedra Research Chanca Piedra (Phyllanthus niruri) is a plant from
the amazon rain forest whose name is translated from Spanish as "Stone
Break". Chanca Piedra has a long traditional history of use for urinary
health but also has been the subject of substantial scientific research.
As with cranberry, we use it for its urinary health, but traditional and
scientifically documented benefits include many other functions. 1.
Boim MA,
Heilberg IP,
Schor N.
Int Braz J Urol.
Phyllanthus
niruri as a promising alternative treatment for
nephrolithiasis. 2010 Nov-Dec;36(6):657-64; discussion 664. Link to Full Text:
http://www.brazjurol.com.br/november_december_2010/Boim_657_664.htm 2. Narayanan AS, Raja SS, Ponmurugan K, Kandekar
SC, Natarajaseenivasan K, Maripandi A, Mandeel QA.
Antibacterial activity of selected medicinal plants against multiple
antibiotic resistant uropathogens: a study from Kolli Hills, Tamil Nadu,
India.
Benef Microbes. 2011 Sep;2(3):235-43. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/21986363 3. Murugaiyah V, Chan KL.Mechanisms
of antihyperuricemic effect of
Phyllanthus niruri
and its lignan constituents.
J
Ethnopharmacol. 2009 Jul 15;124(2):233-9. Epub 2009 May 3. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/19397979 4. Manjrekar AP, Jisha V, Bag PP, Adhikary B, Pai
MM, Hegde A, Nandini M.
Effect of Phyllanthus
niruri Linn. treatment on
liver, kidney and testes in CCl4 induced hepatotoxic rats.
Indian J Exp Biol. 2008 Jul;46(7):514-20. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/18807755 5.
Barros ME, Lima R, Mercuri LP, Matos JR, Schor N, Boim MA.Effect
of extract of Phyllanthus
niruri on crystal
deposition in experimental urolithiasis.
Urol Res. 2006 Dec;34(6):351-7. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/16896689 6.
Freitas AM,
Schor N,
Boim MA. The effect of
Phyllanthus
niruri on
urinary inhibitors of calcium oxalate crystallization
and other factors associated with renal stone formation.
BJU
Int. 2002 Jun;89(9):829-34. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/12010223 7. Nishiura JL, Campos AH, Boim MA, Heilberg IP,
Schor N.
Phyllanthus
niruri normalizes elevated
urinary calcium levels in calcium stone forming (CSF) patients.
Urol Res. 2004 Oct;32(5):362-6. Epub 2004 Jun 19. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/15221244 8. Campos AH, Schor N.
Phyllanthus
niruri inhibits calcium oxalate endocytosis by renal tubular cells: its
role in urolithiasis.Nephron.
1999;81(4):393-7. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/10095174 9. Calixto JB, Santos AR, Cechinel Filho V, Yunes
RA.
A review of the plants of the genus
Phyllanthus: their
chemistry, pharmacology, and therapeutic potential.
Med Res Rev. 1998 Jul;18(4):225-58. Review. Link to
Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/9664291 10. Ranilla LG, Apostolidis E, Shetty K.Antimicrobial
Activity of an Amazon Medicinal Plant (Chancapiedra)
(Phyllanthus niruri L.) against Helicobacter pylori and Lactic Acid
Bacteria.Phytother
Res. 2011 Oct 28. doi: 10.1002/ptr.3646. [Epub ahead of
print] Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/22034238 11. Ranilla LG, Kwon YI, Apostolidis E, Shetty K.
Phenolic compounds, antioxidant activity and in vitro inhibitory
potential against key enzymes relevant for hyperglycemia and
hypertension of commonly used medicinal plants, herbs and spices in
Latin America.
Bioresour Technol. 2010 Jun;101(12):4676-89. Epub 2010 Feb
25. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/20185303 12. Asare GA, Addo P, Bugyei K, Gyan B, Adjei S,
Otu-Nyarko LS, Wiredu EK, Nyarko A.
Acute toxicity studies of aqueous leaf extract of
Phyllanthus niruri.
Interdiscip Toxicol. 2011 Dec;4(4):206-10. Link to Full Text:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3274729/pdf/ITX-4-206.pdf 14. Asare GA, Bugyei K, Sittie A, Yahaya ES, Gyan
B, Adjei S, Addo P, Wiredu EK, Adjei DN, Nyarko AK.Genotoxicity,
cytotoxicity and toxicological evaluation of whole plant extracts of the
medicinal plant Phyllanthus
niruri (Phyllanthaceae).
Genet Mol Res. 2012 Jan 13;11(1):100-11. Link to Full Text:
http://www.geneticsmr.com//year2012/vol11-1/pdf/gmr1315.pdf 15. Amin ZA, Abdulla MA, Ali HM, Alshawsh MA, Qadir
SW.
Assessment of In vitro antioxidant, antibacterial and immune activation
potentials of aqueous and ethanol extracts of
Phyllanthus niruri.
J Sci Food Agric.
2012 Jan 9. doi: 10.1002/jsfa.5554. [Epub ahead of print] Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/22231455 16. Boeira VT, Leite CE, Santos AA Jr, Edelweiss
MI, Calixto JB, Campos MM, Morrone FB.
Effects of the hydroalcoholic extract of
Phyllanthus niruri and
its isolated compounds on cyclophosphamide-induced hemorrhagic cystitis
in mouse.
Naunyn Schmiedebergs Arch
Pharmacol. 2011 Sep;384(3):265-75. doi:
10.1007/s00210-011-0668-0. Epub 2011 Jul 23. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/21789632 17. Okoli CO, Obidike IC, Ezike AC, Akah PA, Salawu
OA.
Studies on the possible mechanisms of antidiabetic activity of extract
of aerial parts of Phyllanthus
niruri.
Pharm Biol. 2011
Mar;49(3):248-55. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/21323477 18. Obidike IC, Salawu OA, Ndukuba M, Okoli CO,
Osunkwo UA.
The Anti-Inflammatory and Antinociceptive Properties of the Chloroform
Fraction From Phyllanthus
niruri Plant Is Mediated via the Peripheral Nervous System.
J Diet Suppl. 2010 Dec;7(4):341-50. Epub 2010 Oct 11. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/22432563 19. Woottisin S, Hossain RZ, Yachantha C,
Sriboonlue P, Ogawa Y, Saito S.
Effects of Orthosiphon grandiflorus, Hibiscus sabdariffa and
Phyllanthus amarus
extracts on risk factors for urinary calcium oxalate stones in rats.
J Urol. 2011 Jan;185(1):323-8. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/21075390 20. Nworu CS, Akah PA, Okoye FB, Esimone CO.
Aqueous extract of Phyllanthus
niruri (Euphorbiaceae) enhances the phenotypic and functional maturation
of bone marrow-derived dendritic cells and their antigen-presentation
function.
Immunopharmacol Immunotoxicol.
2010 Sep;32(3):393-401. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/20095802 21. Huang ST, Wang CY, Yang RC, Wu HT, Yang SH,
Cheng YC, Pang JH.Ellagic Acid, the Active Compound of
Phyllanthus urinaria, Exerts In Vivo Anti-angiogenic Effect and
Inhibits MMP-2 Activity.
Evid Based Complement Alternat Med. . [Epub ahead of
print] Link to Full Text:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095481/pdf/ECAM2011-215035.pdf 22. Sharma P, Parmar J, Verma P, Sharma P, Goyal
PK.
Anti-tumor activity of
Phyllanthus niruri (a medicinal plant) on chemical-induced skin
carcinogenesis in mice.
Asian Pac J Cancer Prev.
2009;10(6):1089-94.
Link to Full Text:
http://www.apocpcontrol.org/page/popup_paper_file_view.php?pno=MTA4OV9jX1NoYSZrY29kZT0xMTEz&pgubun=i 23. Thippeswamy AH,
Shirodkar A,
Koti BC,
Sadiq AJ,
Praveen DM,
Swamy AH,
Patil M. Protective role of Phyllantus niruri
extract in doxorubicin-induced myocardial toxicity in rats.
Indian J Pharmacol. 2011 Feb;43(1):31-5. 24. Sarkar MK, Sil PC.
Prevention of tertiary butyl hydroperoxide induced oxidative impairment
and cell death by a novel antioxidant protein molecule isolated from the
herb, Phyllanthus niruri.
Toxicol In Vitro. 2010 Sep;24(6):1711-9. Epub 2010 May 25. 25. Sarkar MK, Sil PC.
Hepatocytes are protected by herb
Phyllanthus niruri
protein isolate against thioacetamide toxicity.
Pathophysiology. 2007 Oct;14(2):113-20. 26. Shakil NA, Pankaj, Kumar J, Pandey RK, Saxena
DB.
Nematicidal prenylated flavanones from
Phyllanthus niruri.
Phytochemistry.
2008 Feb;69(3):759-64. Epub 2007 Sep 29. 27. Bagalkotkar G, Sagineedu SR, Saad MS, Stanslas
J.
Phytochemicals from Phyllanthus
niruri Linn. and their pharmacological properties: a review.
J
Pharm Pharmacol. 2006 Dec;58(12):1559-70. Review. 28. Iizuka T, Nagai M, Taniguchi A, Moriyama H,
Hoshi K.
Inhibitory effects of methyl brevifolincarboxylate isolated from
Phyllanthus niruri L. on platelet aggregation.
Biol Pharm Bull. 2007 Feb;30(2):382-4. 28. Bhattacharjee R, Sil PC.
Protein isolate from the herb,
Phyllanthus niruri L. (Euphorbiaceae), plays hepatoprotective
role against carbon tetrachloride induced liver damage via its
antioxidant properties.
Food Chem Toxicol. 2007 May;45(5):817-26. Epub 2006 Nov
11. 29. Chatterjee
M, Sil PC.
Hepatoprotective effect of aqueous extract of
Phyllanthus niruri on
nimesulide-induced oxidative stress in vivo.
Indian J Biochem Biophys. 2006 Oct;43(5):299-305. 30. Murugaiyah V, Chan KL.
Antihyperuricemic lignans from the leaves of
Phyllanthus niruri.
Planta Med.
2006 Nov;72(14):1262-7. Epub 2006 Sep 31. Iizuka T, Moriyama H, Nagai M.
Vasorelaxant effects of methyl brevifolincarboxylate from the leaves of
Phyllanthus niruri.
Biol Pharm Bull. 2006 Jan;29(1):177-9. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/16394535 32. Mellinger CG, Carbonero ER, Noleto GR, Cipriani
TR, Oliveira MB, Gorin PA, Iacomini M.
Chemical and biological properties of an arabinogalactan from
Phyllanthusniruri.
J Nat Prod. 2005
Oct;68(10):1479-83. Link to Absract:
http://www.ncbi.nlm.nih.gov/pubmed/16252911 Dandelion Root Research 1.
Chatterjee SJ,
Ovadje P,
Mousa M,
Hamm C,
Pandey S. The efficacy of
dandelion
root extract in inducing apoptosis in drug-resistant
human melanoma cells.
Evid Based Complement Alternat Med.
2011;2011:129045. Epub 2010 Dec 30. Link to Free Full Text:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018636/?tool=pubmed 2.
Ovadje P,
Chatterjee S,
Griffin C,
Tran C,
Hamm C,
Pandey S.
Selective induction of apoptosis through activation of caspase-8 in human
leukemia cells (Jurkat) by dandelion root extract.
J
Ethnopharmacol.
2011 Jan 7;133(1):86-91. Epub 2010 Sep 16.
Link
to Abstract:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018636/?tool=pubmed 3.
Domitrović R,
Jakovac H,
Romić Z,
Rahelić D,
Tadić Z. Antifibrotic activity of
Taraxacum officinale
root in carbon tetrachloride-induced liver damage in
mice.
J Ethnopharmacol. 2010 Aug 9;130(3):569-77. Epub 2010 Jun 2. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/20561925 4..
Mahesh A,
Jeyachandran R,
Cindrella L,
Thangadurai D,
Veerapur VP,
Muralidhara Rao D.Hepatocurative potential of
sesquiterpene lactones of
Taraxacum officinale on carbon tetrachloride induced
liver toxicity in mice.
Acta Biol Hung. 2010 Jun;61(2):175-90.
Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/20519172 5.
You Y,
Yoo S,
Yoon HG,
Park J,
Lee YH,
Kim S,
Oh KT,
Lee J,
Cho HY,
Jun W. In vitro and in vivo hepatoprotective
effects of the aqueous extract from
Taraxacum officinale (dandelion)
root against alcohol-induced oxidative stress.
Food Chem Toxicol. 2010 Jun;48(6):1632-7. Epub 2010
Mar 27. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/20347918 6.
Choi UK,
Lee OH,
Yim JH,
Cho CW,
Rhee YK,
Lim SI,
Kim YCInt.
Hypolipidemic and antioxidant effects of dandelion (Taraxacum
officinale) root and leaf on cholesterol-fed rabbits.
J
Mol Sci. 2010 Jan 6;11(1):67-78.
Link
to Free Full Text:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2820990/?tool=pubmed
7.
Ung-Kyu Choi,1
Ok-Hwan Lee,2,*
Joo Hyuk Yim,3
Chang-Won Cho,3
Young Kyung Rhee,3
Seong-Il Lim,3 and
Young-Chan Kim3,* Hypolipidemic and
Antioxidant Effects of Dandelion (Taraxacum officinale)
Root and Leaf on Cholesterol-Fed Rabbits.
Int J Mol Sci.
2010 January;
11(1):
67–78.
Link
to Full Text:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2820990/?tool=pubmed 8.
Schütz K,
Carle R,
Schieber A.
Taraxacum--a
review on its phytochemical and pharmacological profile.
J Ethnopharmacol. 2006 Oct 11;107(3):313-23. Epub 2006 Jul
22. Link to abstract:
http://www.ncbi.nlm.nih.gov/pubmed/16950583 9.
Schütz K,
Kammerer DR,
Carle R,
Schieber A. Characterization of phenolic acids and
flavonoids in
dandelion (Taraxacum
officinale WEB. ex WIGG.)
root and herb by high-performance liquid
chromatography/electrospray ionization mass spectrometry.
Rapid Commun Mass Spectrom. 2005;19(2):179-86.Link
to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/15593267 10.
Trojanová I,
Rada V,
Kokoska L,
Vlková E. The bifidogenic effect of
Taraxacum officinale
root.
Fitoterapia. 2004 Dec;75(7-8):760-3. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/15567259 11.
Hussain Z,
Waheed A,
Qureshi RA,
Burdi DK,
Verspohl EJ,
Khan N,
Hasan M. The effect of medicinal plants of
Islamabad and Murree region of Pakistan on insulin secretion from INS-1
cells.
Phytother Res. 2004 Jan;18(1):73-7. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/14750205 12.
Kashiwada Y,
Takanaka K,
Tsukada H,
Miwa Y,
Taga T,
Tanaka S,
Ikeshiro Y. Sesquiterpene glucosides from
anti-leukotriene B4 release fraction of
Taraxacum
officinale.
J Asian Nat Prod Res. 2001;3(3):191-7.Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/11491394 13. Hata K, Ishikawa K, Hori K, Konishi T.
Differentiation-inducing activity of lupeol, a lupane-type triterpene
from Chinese dandelion
root (Hokouei-kon), on a mouse melanoma cell line.
Biol Pharm Bull. 2000 Aug;23(8):962-7. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/10963304 14. Kisiel W, Barszcz B.Further
sesquiterpenoids and phenolics from
Taraxacum officinale.
Fitoterapia. 2000 Jun;71(3):269-73. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/10844166 15.
Bogacheva AM,
Rudenskaya GN,
Preusser A,
Tchikileva IO,
Dunaevsky YE,
Golovkin BN,
Stepanov VM. A new subtilisin-like proteinase from
roots of the
dandelion
Taraxacum officinale Webb S. L.
Biochemistry (Mosc). 1999 Sep;64(9):1030-7. Link to Free
Full Text:
http://protein.bio.msu.ru/biokhimiya/contents/v64/full/64091224.html 16.
Takasaki M,
Konoshima T,
Tokuda H,
Masuda K,
Arai Y,
Shiojima K,
Ageta H. Anti-carcinogenic activity of
Taraxacum
plant. I.
Biol Pharm Bull. 1999 Jun;22(6):602-5. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/10408234 17.
Takasaki M,
Konoshima T,
Tokuda H,
Masuda K,
Arai Y,
Shiojima K,
Ageta H. Anti-carcinogenic activity of
Taraxacum
plant. II.
Biol Pharm Bull. 1999 Jun;22(6):606-10. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/10408235 18.
Taraxalisin -- a serine proteinase from
dandelion
Taraxacum officinale Webb s.l. Rudenskaya GN, Bogacheva
AM, Preusser A, Kuznetsova AV, Dunaevsky YaE, Golovkin BN, Stepanov VM.
FEBS Lett. 1998 Oct 23;437(3):237-40. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/9824298 19. Williams CA, Goldstone F, Greenham J.
Flavonoids, cinnamic acids and coumarins from the different tissues and
medicinal preparations of
Taraxacum officinale.
Phytochemistry. 1996 May;42(1):121-7. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/8728061 Uva Ursi (Arctostaphylos uva-ursi)
Research 1.
Lee HJ,
Kim KW. Anti-inflammatory effects of arbutin in
lipopolysaccharide-stimulated BV2 microglial cells.
Inflamm Res. 2012 Apr 10. [Epub ahead of print] Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/22487852 2.
Li H,
Jeong YM,
Kim SY,
Kim MK,
Kim DS. Arbutin inhibits TCCSUP human bladder
cancer cell proliferation via up-regulation of p21.Pharmazie. 2011 Apr;66(4):306-9. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/21612160 3.
Alam P,
Alqasoumi SI,
Shakeel F,
Abdel-Kader MS. HPTLC densitometric analysis of
arbutin in bulk drug and methanolic extracts of
Arctostaphylos
uva-ursi.
Nat Prod Res. 2011 Oct;25(17):1671-5. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/21331974 4.
Takada K,
Nakane T,
Masuda K,
Ishii H. Ursolic acid and oleanolic acid, members
of pentacyclic triterpenoid acids, suppress TNF-α-induced E-selectin
expression by cultured umbilical vein endothelial cells.
Phytomedicine. 2010 Dec 1;17(14):1114-9. Epub 2010
Jun 25. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/20579861 5.
Head KA. Natural approaches to prevention and
treatment of infections of the lower urinary tract.
Altern Med Rev. 2008 Sep;13(3):227-44. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/18950249 6.
Chauhan B,
Yu C,
Krantis A,
Scott I,
Arnason JT,
Marles RJ,
Foster BC. In vitro activity of
uva-ursi against cytochrome P450 isoenzymes and
P-glycoprotein.
Can J Physiol Pharmacol. 2007 Nov;85(11):1099-107.
Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/18066112 7.
Yarnell E. Botanical medicines for the urinary
tract. World
J Urol. 2002 Nov;20(5):285-93. Epub 2002 Oct 17.Link to
Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/12522584 8. Schindler G, Patzak U, Brinkhaus B, von Niecieck
A, Wittig J, Krähmer N, Glöckl I, Veit M.Urinary
excretion and metabolism of arbutin after oral administration of
Arctostaphylos uvae
ursi extract as
film-coated tablets and aqueous solution in healthy humans.
J Clin Pharmacol. 2002 Aug;42(8):920-7. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/12162475 9.
Newton M,
Combest W,
Kosier JH. Select herbal remedies used to treat
common urologic conditions.Urol
Nurs. 2001 Jun;21(3):232-4. 10. Grases F, Melero G, Costa-Bauzá A, Prieto R,
March JG.
Urolithiasis and phytotherapy. Int
Urol Nephrol. 1994;26(5):507-11. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/7860196 11. Matsuda H, Nakamura S, Tanaka T, Kubo M.[Pharmacological
studies on leaf of
Arctostaphylos uva-ursi
(L.) Spreng. V. Effect of water extract from
Arctostaphylos
uva-ursi (L.) Spreng.
(bearberry leaf) on the antiallergic and antiinflammatory activities of
dexamethasone ointment].
Yakugaku Zasshi. 1992 Sep;112(9):673-7. Japanese. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/1469616 12. Swanston-Flatt SK, Day C, Bailey CJ, Flatt PR.Evaluation
of traditional plant treatments for diabetes: studies in streptozotocin
diabetic mice.
Acta
Diabetol Lat. 1989 Jan-Mar;26(1):51-5. Link to Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/2750445 13. Frohne D.[The
urinary disinfectant effect of extract from leaves
uva ursi].Planta
Med. 1970 Jan;18(1):1-25. German. No abstract available. |